Committee for Medicinal Products for Human Use

From Wikipedia, the free encyclopedia
Jump to: navigation, search
"CHMP" redirects here. For the French language Canadian radio station, see CHMP-FM.

The Committee for Medicinal Products for Human Use (CHMP), formerly known as Committee for Proprietary Medicinal Products (CPMP), is the European Medicines Agency's committee responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use. For example, on May 31, 2013, the committee recommended marketing authorization for a new smallpox immunization called IMVANEX.[1]


  1. ^ Limardo, Jessica (June 4, 2013). "IMVANEX receives positive opinion for marketing in EU and EEA". BioPrepWatch. Retrieved 6 June 2013. 

External links[edit]